Patents by Inventor Xiaoming Zhang

Xiaoming Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20180016222
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: June 8, 2017
    Publication date: January 18, 2018
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • INSTANT MESSAGING ROBOT TO PROVIDE PRODUCT INFORMATION
    Publication number: 20170364979
    Abstract: Methods and systems to automatically respond to a request for product information are described. In one embodiment, a data collection module may collect product data over a network, identify that the product data is related to a particular product, and store the product data and an association between the product data and the particular product in a database. An instant messaging engine may receive a request for the product data after the product data is stored in the database and an interpreter module may identify, in response to the request, the request to correspond to the particular product and retrieve the product data based on the association between the particular product and the product data. The instant messaging engine may also transmit, using an instant messaging protocol, a response to the request, the response including the product data.
    Type: Application
    Filed: August 30, 2017
    Publication date: December 21, 2017
    Inventor: Xiaoming Zhang
  • Treprostinil derivative compounds and methods of using same
    Patent number: 9845305
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable dosage. Transdermal applications can be used.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: December 19, 2017
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. Becker, Jürg R. Pfister, Gwenaella Rescourio, Meenakshi S. Venkatraman, Xiaoming Zhang
  • USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS
    Publication number: 20170348283
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Application
    Filed: June 16, 2017
    Publication date: December 7, 2017
    Inventors: Xiaoming ZHANG, Edward F. SCHNIPPER, Andrew J. PERLMAN, James W. LARRICK
  • USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS
    Publication number: 20170348282
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Application
    Filed: June 16, 2017
    Publication date: December 7, 2017
    Inventors: Xiaoming ZHANG, Edward F. SCHNIPPER, Andrew J. PERLMAN, James W. LARRICK
  • System and method for parallel power supply control for auxiliary converters of motor train unit in presence of interconnecting lines
    Patent number: 9809118
    Abstract: A system and a method for parallel power supply control for auxiliary converters of a motor train unit in the presence of interconnecting lines. The system comprises multiple three-phase inverter modules. The multiple three-phase inverter modules are in parallel connection with each other. Any two-phase circuit of a three-phase inverter module is separately in parallel connection with a corresponding two-phase circuit of a three-phase inverter module adjacent to the three-phase inverter module by using a connecting line module. The connecting line module is connected to a control system. The three-phase inverter modules are also connected to the control system. The three-phase lines of the three-phase inverter modules are all provided with switches.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: November 7, 2017
    Assignee: CRRC QINGDAO SIFANG ROLLING STOCK RESEARCH INSTITUTE CO., LTD.
    Inventors: Dongjun Yang, Bo Li, Junlei Wei, Bo Zhang, Zhaoping Li, Xiaoming Zhang, Zheng Xie, Yang Zhou, Lijun Zhang, Yanfang Zhang
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20170298001
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: March 29, 2017
    Publication date: October 19, 2017
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • DIGITAL MODEL OPTIMIZATION RESPONSIVE TO ORIENTATION SENSOR DATA
    Publication number: 20170287059
    Abstract: A system server includes a database of two-dimensional images and a processor coupled to a hardware memory with instructions that in response to execution by the processor direct performance of operations. The operations include generating a digital model from the images in the database and communicating a first portion of the digital model as an enhanced view to a user device. The first portion corresponds to a first line of sight orientation of the user device as measured by an orientation sensor. The operations include receiving a signal based on sensor data measured by the orientation sensor. The signal indicates movement of the user device from the first line of sight orientation to a second line of sight orientation. In response, the method includes communicating a second portion of the digital model to the user device that corresponds to the second line of sight orientation of the user device.
    Type: Application
    Filed: March 30, 2017
    Publication date: October 5, 2017
    Inventors: Marcus Shelksohn, Fernando Villarreal, Khashayar Dehdashtinejad, Matthew Wolf, Jordan Springstroh, Jonathan Zhang, Yuquan Yang, Xiaoming Zhang, Zoran Dukic
  • Instant messaging robot to provide product information
    Patent number: 9779437
    Abstract: Methods and systems to automatically respond to a request for product information are described. In one embodiment, a data collection module may collect product data over a network, identify that the product data is related to a particular product, and store the product data and an association between the product data and the particular product in a database. An instant messaging engine may receive a request for the product data after the product data is stored in the database and an interpreter module may identify, in response to the request, the request to correspond to the particular product and retrieve the product data based on the association between the particular product and the product data. The instant messaging engine may also transmit, using an instant messaging protocol, a response to the request, the response including the product data.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: October 3, 2017
    Assignee: eBay Inc.
    Inventor: Xiaoming Zhang
  • Treprostinil derivative compounds and methods of using same
    Patent number: 9776982
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: October 3, 2017
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang
  • LOWER GRILLE ASSEMBLY PREVENTING LIGHT LEAKAGE
    Publication number: 20170253206
    Abstract: A lower grille assembly preventing light leakage and fixedly connected to a bumper skin of a vehicle and comprising a lower grille body with a buckle mounting orifice and a lower grille trim with a buckle, wherein the lower grille trim is fixedly connected to the lower grille body by means of the buckle and the buckle mounting orifice; a buckle flange extending outward on the buckle of the lower grille trim, the buckle including a U-shaped groove for receiving an end of the skin and in a clearance fit with the end, so as to clamp and support the skin, effectively ensuring a Z-direction clearance between the trim and the skin, preventing the skin from falling due to its dead weight, and avoiding light leakage due to an increased Z-direction clearance between the skin and the lower grille assembly resulting from deformation of the lower grille assembly.
    Type: Application
    Filed: August 6, 2015
    Publication date: September 7, 2017
    Applicants: Compagnie Plastic Omnium, Yanfeng Plastic Omium Automotive Exterior Systems Co., Ltd.
    Inventors: Xiaoming ZHANG, Li CHENG, Wufan LI
  • Use of NK-1 receptor antagonist serlopitant in pruritus
    Patent number: 9737507
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: August 22, 2017
    Assignee: MENLO THERAPEUTICS INC.
    Inventors: Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
  • Use of NK-1 receptor antagonists in pruritus
    Patent number: 9737508
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: August 22, 2017
    Assignee: MENLO THERAPEUTICS INC.
    Inventors: Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
  • SYSTEMS AND METHODS FOR THE CLASSIFICATION AND INDEXING OF CONTRACT DOCUMENTATION
    Publication number: 20170206326
    Abstract: A request for contract documentation is received from a provider computer. One or more classifier values associated with the request are compared to one or more values stored in one or more index cores. Based on the determination that a match exists, one or more contracting documents are retrieved from a contracts database, where the contracts database includes the updated format of each of the contracting documents. A contract template is generated including the one or more contracting documents. The contract template is compiled and communicated for signature and subsequent approval.
    Type: Application
    Filed: January 20, 2016
    Publication date: July 20, 2017
    Inventors: Julian Oliver Klein, Shiradwade Sateesh Krishna, Xiaoming Zhang, Michael Anthony Zupper, Amit Arun Dalvi
  • Use of NK-1 receptor antagonist serlopitant in pruritus
    Patent number: 9707208
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: July 18, 2017
    Assignee: MENLO THERAPEUTICS INC.
    Inventors: Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
  • Use of NK-1 receptor antagonists in pruritus
    Patent number: 9707209
    Abstract: The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: July 18, 2017
    Assignee: MENLO THERAPEUTICS INC.
    Inventors: Xiaoming Zhang, Edward F. Schnipper, Andrew J. Perlman, James W. Larrick
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 9701616
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: July 11, 2017
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Detecting apparatus and detecting method
    Patent number: 9671460
    Abstract: The present invention provides a detecting apparatus and a detecting method. The detecting apparatus comprises: a base, a light source module, an image generating unit and a detecting unit. The light source module is configured to generate detecting light and cause the detecting light to irradiate towards the image generating unit after passing through an area of a shorting bar circuit in a panel. The image generating unit is configured to receive the detecting light irradiating thereon, and generate a detecting image of the area of the shorting bar circuit. The detecting unit is configured to detect whether the shorting bar circuit in the panel is cut off based on the detecting image. As the detecting light passing through the panel lasts for a longer time and is of higher brightness, the detecting image generated by the image generating unit is clearer.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 6, 2017
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., HEFEI XINSHENG OPTOELECTRONICS TECHNOLOGY CO., LTD.
    Inventors: Chuanbing Wei, Xiaoming Zhang, Song Wu
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 9643911
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: May 9, 2017
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20170081303
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: October 18, 2016
    Publication date: March 23, 2017
    Inventors: Cyrus K. BECKER, Jürg R. PFISTER, Gwenaella RESCOURIO, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG